Iron Overload and the Biliary Route

  • Pierre Brissot
  • Yves Deugnier
  • Dominique Guyader
  • Giuliana Zanninelli
  • Olivier Loréal
  • Romain Moirand
  • Gérard Lescoat
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 356)

Abstract

Iron, like other metals, is not destroyed within the body and therefore, in order to limit its biological and/or toxic effects, must be eliminated. Various elimination pathways exist physiologically, ensuring a balance with the amount of iron absorbed by the intestine, Le.1 to 2 mg per day corresponding to about 10 per cent of a normal diet containing 10-20 mg of iron 1. Iron losses occur mainly through exfoliated intestinal epithelial cells, smaller amounts being lost via the skin (desquamated cells and sweat) or by urinary route (0.1 mg daily). The biliary elimination of iron has classically been considered as a minor pathway. However, recent data from both human and experimental studies emphasize the importance of the biliary excretion route.

Keywords

Cholesterol Carbohydrate Carbonyl Ferritin Transferrin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    P. Brissot and Y. Deugnier, Normal iron metabolism. Oxford Textbook of Clinical Hepatology, Ed. N Mclntyre, JP Benhamou, J Bircher, M Rizzetto and J Rodes, Oxford University Press 221 (1991).Google Scholar
  2. 2.
    R. Green, R. Charlton, H. Seftel, T. Bothwell, F. Mayet, B. Adams, C. Finch, and M. Layrisse, Body iron excretion in man, A collaborative study, Am J Physiol 45: 336 (1968).Google Scholar
  3. 3.
    R. Hultcrantz, B. Angelin, E. Björn-Rasmussen, S. Ewerth, and K. Einarsson, Biliary excretion of iron and ferritin in idiopathic hemochromatosis, Gastroenterology 96: 1539 (1989).PubMedGoogle Scholar
  4. 4.
    K. Einarsson, K. Nilsell, B. Leidj, and B. Angelin, Influence of age on secretion of cholesterol and synthesis of bile acids by the liver, N Engl J Med 313: 277 (1985).PubMedCrossRefGoogle Scholar
  5. 5.
    R. Raedsch, A. Stiehl, S. Walker, L. Theilmann, B. Kommerell, R. Waldherr, and M. Senn, Biliary excretion of iron in healthy man and in patients with alcoholic cirrhosis of the liver, Clin Chim Acta 193: 49 (1990).PubMedCrossRefGoogle Scholar
  6. 6.
    A. Jacobs and P.M. Miles, The formation of iron complexes with bile and bile constituents, Gut 11: 732 (1970).PubMedCrossRefGoogle Scholar
  7. 7.
    N.F. LaRusso, Proteins in bile: how they get there and what they do, Am J Physiol 247: G 199 (1984).Google Scholar
  8. 8.
    T.C. Iancu, Ultrastructural pathology of iron overload, Baillière’s Clin Haematol 2: 475 (1989).CrossRefGoogle Scholar
  9. 9.
    Y. Deugnier, O. Loréal, B. Turlin, D. Guyader, H. Jouanolle, R. Moirand, C. Jacquelinet, and P. Brissot, Liver pathology in genetic hemochromatosis: A review of 135 homozygous cases and their bioclinical correlations, Gastroenterology 102: 2050 (1992).PubMedGoogle Scholar
  10. 10.
    M. Cleton, J.W. Sindram, L.P.M. Rademakers, F.M.J. Zuyderhoudt, W.C. De Bruijn, and J.J.M. Marx, Ultrastructural evidence for the presence of ferritin-iron in the biliary system of patients with iron overload, Hepatology 6: 30 (1986).PubMedCrossRefGoogle Scholar
  11. 11.
    P.J. Scheuer. Liver biopsy interpretation. 2nd ed. London: Baillère. Tindall and Cassell 1977.Google Scholar
  12. 12.
    Y.M. Deugnier, A.F. Rabot, R. Moirand, D. Le Quilleuc, D. Guyader, C. Jacquelinet, B. Turlin, and P. Brissot, Serum increase and liver overexpression of the carbohydrate 19.9 antigen in patients with untreated genetic hemochromatosis, Abst 4th International Conference on hemochromatosisi and Clinical Problems in Iron Metabolism, Jerusalem (April 27-May 1, 1993).Google Scholar
  13. 13.
    W.D. Bradford, J.G. Elchlepp, A.U. Arstila, B.F. Trump, and T.D. Kinney, Iron metabolism and cell membranes, I Relation between ferritin and hemosiderin in bile and biliary excretion of lysosome contents, Am J Pathol 56: 201 (1969).PubMedGoogle Scholar
  14. 14.
    P. Brissot, J. Farjanel, D. Bourel, J.P. Campion,Guillouzo, A. Rattner, Y. Deugnier, B. Desvergne, B. Ferrand, M. Simon, and M. Bourel, Chronic liver iron overload in the baboon by ferric nitrilotriacetate. Morphologic and functional changes with special emphasis to collagen synthesis enzymes, Dig Dis Sci 32: 620 (1987).PubMedCrossRefGoogle Scholar
  15. 15.
    R.T. Parmley, M.E. May, S.S. Spicer, M.G. Buse, and C.J. Alvarez, Ultrastructural distribution of inorganic iron in normal and iron-overloaded hepatic cells, Lab Invest 44: 475 (1981).PubMedGoogle Scholar
  16. 16.
    B.R. Bacon, A.S. Tavill, G.M. Brittenham, C.H. Park and R.O. Recknagel, Hepatic lipid peroxidation in vivo in rats with chronic iron overload, J Clin Invest 71: 429 (1983).PubMedCrossRefGoogle Scholar
  17. 17.
    C.H. Park, B.R. Bacon, G.M. Brittenham, and A.S. Tavill, Pathology of dietary carbonyl iron overload in rats, Lab Invest 57: 555 (1987).PubMedGoogle Scholar
  18. 18.
    G.D. LeSage, L.J. Kost, S.S. Barham, and N.F. LaRusso, Biliary excretion of iron from hepatocyte lysosomes in the rat. A major excretory pathway in experimental iron overload, J Clin Invest 77: 90 (1986).PubMedCrossRefGoogle Scholar
  19. 19.
    P. Lévy, M. Dumont, P. Brissot, A. Letreut, A. Favier, Y. Deugnier, and S. Erlinger, Acute infusions of bile salts increase biliary excretion of iron in iron-loaded rats, Gastroenterology 101: 1673 (1991).PubMedGoogle Scholar
  20. 20.
    R.A. Marinelli, C.E. Carnovale, and E.A. Rodriguez Garay, Bile protein secretion in the rat stimulated by taurocholate: effect of chloroquine, Can J Physiol Pharmacol. 66: 749 (1988).PubMedCrossRefGoogle Scholar
  21. 21.
    K. Rahman and R. Coleman, Output of lysosomal contents and cholesterol into bile can be stimulated by taurodehydrocholate, Biochem J 245: 289 (1987).PubMedGoogle Scholar
  22. 22.
    P. Brissot, T.L. Wright, W.L. Ma, and R.A. Weisiger, Efficient clearance of non-transferrin-bound iron by rat liver: Implications for hepatic iron loading in iron overload states, J Clin Invest 76: 1463 (1986).CrossRefGoogle Scholar
  23. 23.
    T.L. Wright, P. Brissot, W.L. Ma, and R.A. Weisiger, Characterization of non-transferrin bound iron clearance by rat liver, J Biol Chem 261: 10909 (1986).PubMedGoogle Scholar
  24. 24.
    D. Guyader, G. Zanninelli, and P. Brissot, Fer non lié à la transferrine et charge hépatique en fer, Gastroenterol Clin Biol 16: 756 (1992).PubMedGoogle Scholar
  25. 25.
    P. Brissot, G. Zanninelli, D. Guyader, J. Zeind, and J. Gollan, Biliary excretion of plasma non-transferrin-bound iron: a significant excretory pathway in normal but not in chronically iron overloaded rats, Am J Physiol (in press).Google Scholar
  26. 26.
    J.B. Porter, E.R. Huehns, and R.C. Hider, The development of iron chelating drugs, Baillière’s Clin Haematol 2: 257 (1989).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Pierre Brissot
    • 1
  • Yves Deugnier
    • 1
  • Dominique Guyader
    • 1
  • Giuliana Zanninelli
    • 1
  • Olivier Loréal
    • 1
  • Romain Moirand
    • 1
  • Gérard Lescoat
    • 1
  1. 1.Clinique des Maladies du Foie and INSERM Unit 49University Hospital PontchaillouRennesFrance

Personalised recommendations